Skip to main content

Advertisement

Log in

Comparison of subareolar injection lymphoscintigraphy with the 1-day and the 2-day protocols for the detection of sentinel lymph nodes in patients with breast cancer

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Lymphoscintigraphy and sentinel node biopsy are used for the detection of axillary lymph node metastasis in breast cancer patients. However, currently there is no standardized technique. For the detection of axillary lymph node metastasis by lymphoscintigraphy and sentinel node biopsy, in patients with breast cancer, we compared the results of subareolar injections administered on the day of surgery (1-day protocol) with injections administered on the day before surgery (2-day protocol).

Materials and methods

This study included 412 breast cancer patients who underwent surgery between 2001 and 2004. For the 1-day protocol (1 h before surgery) 0.8 ml of Tc-99m Tin-Colloid (37 MBq) was injected in 203 in the subareolar region on the morning of the surgery. For the 2-day protocol (16 h before surgery) 0.8 ml of Tc-99m Tin-Colloid (185 MBq) was injected in 209 patients on the afternoon before surgery. Lymphoscintigraphy was performed in the supine position and sentinel node identification was performed by hand-held gamma probe during surgery.

Results

Among 203 patients with the 1-day protocol, 185 cases (91.1%) were identified by sentinel node lymphoscintigraphy, and 182 cases (89.7%) were identified by gamma probe. Among the 209 patients, in the 2-day protocol, 189 cases (90.4%) had the sentinel node identified by lymphoscintigraphy, and 182 cases (87.1%) by the gamma probe. There was no significant difference in the identification rate of the sentinel node between the 1-day and 2-day protocols by lymphoscintigraphy and the gamma probe (p > 0.05, p > 0.05).

Conclusions

The results of the identification of the sentinel node by subareolar injection according to 1-day or 2-day protocol, in breast cancer patients, showed no significant differences. Because the 2-day protocol allows for an adequate amount of time to perform the lymphoscintigraphy, it is a more useful protocol for the identification of sentinel nodes in patients with breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Van der Wall E. The sentinel node in breast cancer: implications for adjuvant treatment? Eur J Nucl Med. 1999;26(Suppl):s17–9.

    Article  PubMed  Google Scholar 

  2. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol. 1996;3:233–4.

    Article  PubMed  CAS  Google Scholar 

  3. Cascinelli N, Greco M, Bufalino R, Clemente C, Galluzzo D, Delle Donne V, et al. Prognosis of breast cancer with axillary lymph node metastases after surgical treatment only. Eur J Cancer Clin Oncol. 1987;23:795–9.

    Article  PubMed  CAS  Google Scholar 

  4. Kissin MW, Querci della Rovere G, Easton D, Westburv G. Risk of lymphedema after the treatment of the breast cancer. Br J Surg. 1986;73:580–4.

    Article  PubMed  CAS  Google Scholar 

  5. Tiourina T, Arends B, Huysmans D, Rutten H, Lemaire B, Muller S. Evaluation of surgical gamma probes for radioguided sentinel node localization. Eur J Nucl Med. 1998;25:1224–31.

    Article  PubMed  CAS  Google Scholar 

  6. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–66.

    Article  PubMed  CAS  Google Scholar 

  7. Morton DL, Wen DR, Wong JH. Technical detail of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.

    PubMed  CAS  Google Scholar 

  8. Krag DN, Weaver DL, Alex JC. Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe. Surg Oncol. 1993;2:335–40.

    Article  PubMed  CAS  Google Scholar 

  9. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345–50.

    PubMed  CAS  Google Scholar 

  10. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer-a multicenter validation study. N Eng J Med. 1998;339:941–6.

    Article  CAS  Google Scholar 

  11. D’Eredita G, Giardina C, Guerrieri AM, Berardi T. A further validation of subareolar injection technique for breast sentinel lymph node biopsy. Ann Surg Oncol. 2006;13:701–7.

    Article  PubMed  Google Scholar 

  12. Peley G, Sinkovies I, Toth J, Farkas E, Keresztes S, Koves I. Subareolar injection of radioactive colloid for sentinel lymph node identification in breast cancer patients. Am Surg. 2004;70:625–9.

    PubMed  Google Scholar 

  13. Maza S, Thomas A, Winzer KJ, Huttner C, Blohmer JU, Hauschild M, et al. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients. Eur J Nucl Med Mol Imaging. 2004;31:671–5.

    Article  PubMed  Google Scholar 

  14. D’Eredita G, Ferrarese F, Cecere V, Massa ST, de Carne F, Fabiano G. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 2003;10:942–7.

    Article  PubMed  Google Scholar 

  15. McCarter MD, Yeung H, Yeh S, Fey J, Borqen PI, Cody HS 3rd. Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection. Ann Surg Oncol. 2001;8:682–6.

    Article  PubMed  CAS  Google Scholar 

  16. Koizumi M, Nomura E, Yamada Y, Takiguchi T, Tanaka K, Yoshimoto M, et al. Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study. Nucl Med Commun. 2003;24:663–70.

    Article  PubMed  CAS  Google Scholar 

  17. Yeung HW, Cody HS III, Turlakow A, Riedel ER, Fey J, Gonen M, et al. Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols. J Nucl Med. 2001;42:420–3.

    PubMed  CAS  Google Scholar 

  18. Gutman F, Sanson A, Piquenot JM, Hitzel A, Ladonne JM, Dessoqne P, et al. Intra-individual comparison of sentinel lymph node scintigraphy on the day of injection and on the following day in breast cancer. Nucl Med Commun. 2006;27:5–9.

    Article  PubMed  Google Scholar 

  19. Jaderbord JM, Harrison PB, Kiser JL, Maynard SL. The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma. Am Surg. 1999;65:704–5.

    Google Scholar 

  20. Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer. 2000;88:2540–5.

    Article  PubMed  CAS  Google Scholar 

  21. Doting MH, Jansen L, Nieweg OE, Piers DA, Tiebosch AT, Koops HS, et al. Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer. 2000;88:2546–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ju Won Seok.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seok, J.W., Kim, I.J., Heo, YJ. et al. Comparison of subareolar injection lymphoscintigraphy with the 1-day and the 2-day protocols for the detection of sentinel lymph nodes in patients with breast cancer. Ann Nucl Med 23, 465–469 (2009). https://doi.org/10.1007/s12149-009-0259-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-009-0259-z

Keywords

Navigation